首页> 外文会议>IEEE International Conference on Big Data and Smart Computing >A Drug-Induced Liver Injury Prediction Model using Transcriptional Response Data with Graph Neural Network
【24h】

A Drug-Induced Liver Injury Prediction Model using Transcriptional Response Data with Graph Neural Network

机译:基于图谱神经网络的转录反应数据的药物诱导的肝损伤预测模型

获取原文

摘要

Drug-Induced Liver Injury (DILI) is a major cause of failed drug candidates in clinical trials and withdrawal of approved drugs from the market. Therefore, machine learning-based DILI prediction can be key in increasing the success rate of drug discovery because drug candidates that are predicted to potentially induce liver injury can be rejected before clinical trials. However, existing DILI prediction models mainly focus on the chemical structures of drugs. Since we cannot determine whether a drug will cause liver injury based solely on its structure, DILI prediction based on the transcriptional effect of a drug on a cell is necessary. In this paper, we propose GLIT which is a model that uses transcriptional response data and chemical structures and can be used for drug-induced liver injury prediction. GLIT learns the embedding vectors of drug structures and drug-induced gene expression profiles using graph attention networks in a biological knowledge graph for predicting DILI. GLIT outperformed a baseline model that uses only drug structure information by 7% and 19.2% in terms of correct classification rate (CCR) and Matthews correlation coefficient (MCC), respectively. In addition, we conducted a literature survey to confirm whether the class labels of drugs, in the unknown DILI class, predicted by GLIT are correct.
机译:药物引起的肝损伤(DILI)是临床试验中候选药物失败以及批准的药物退出市场的主要原因。因此,基于机器学习的DILI预测可能是提高药物发现成功率的关键,因为被预测可能诱发肝损伤的候选药物在临床试验之前可能会被拒绝。但是,现有的DILI预测模型主要关注药物的化学结构。由于我们不能仅凭其结构来确定药物是否会引起肝损伤,因此有必要基于药物对细胞的转录作用进行DILI预测。在本文中,我们提出了GLIT,这是一个使用转录反应数据和化学结构的模型,可用于药物诱导的肝损伤预测。 GLIT使用生物学知识图中的图注意力网络来学习药物结构和药物诱导的基因表达谱的嵌入载体,以预测DILI。 GLIT优于仅使用药物结构信息的基线模型,就正确分类率(CCR)和马修斯相关系数(MCC)而言,分别为7%和19.2%。此外,我们进行了文献调查,以确认GLIT预测的未知DILI类别的药物的类别标签是否正确。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号